Blood Stem Cell Transplantation

Langue : anglais

Edité par Springer, 2012

1461379164 / 9781461379164

Série : Livre 92 sur 180 - Cancer Treatment and Research

Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

Vendeur avec une évaluation de 5 étoiles

Vendeur AbeBooks depuis 14 août 2006

Livre broché

Etat: Neuf

EUR 359,50

EUR 35,00 expédition 
Expédition depuis Allemagne vers Etats-Unis

Quantité disponible : 1 disponible

Ajouter au panier
Retours gratuits sous 30 jours

A propos de cet article

Druck auf Anfrage Neuware - Printed after ordering - Blood Stem Cell Transplantation conveys the excitement that accompanies the newest developments in hematopoietic stem cell transplantation. Some of the applications that stand to impact this field most significantly are based on recent advances in the biological sciences, as demonstrated by the chapters on gene therapy, on the detection of minimal residual disease using molecular techniques, and on the use of radioimmunoconjugates targeting lymphoma and leukemia-associated antigens. Others are the results of clinical observations - e.g., the association between graft-versus-host- disease (GVHD) and durable remissions that have led to creative clinical experiments such as donor leukocyte infusions (DLI). Attempts to unravel the biological events that underlie the responses seen in patients with relapsed chronic myelogenous leukemia treated with DLI are likely to provide the basis for future refinements in this clinical approach. Hopefully, improved response rates and reduced toxicity will result. The power of the immunologic response in controlling malignant disease is underscored in the chapter on post-transplant immunotherapy. The complex immunologic process that results in clinical GVHD may be dissected and engineered to provide clinical benefits that include, in addition to its antineoplastic effects, the amelioration of its clinical manifestations. Better control of GVHD with less global immunosuppression will facilitate the use of mismatched and unrelated donors. This area of investigation perfectly illustrates the continued interplay between the laboratory and the clinic. The continued cross-fertilization of ideas between immunologists, molecular biologists and clinical investigators is likely to yield important advances in this field for years to come. Possible applications of stem cell transplantation continue to grow with the identification of alternative sources of stem cells and the potential to engineer and/orexpand the graft. Although the use of unrelated and mismatched donors continues to increase, the possibilities associated with umbilical cord blood transplantation are legion, especially if stem cells can be expanded ex vivo to provide grafts for full-sized adults. Using techniques in which contaminating malignant cells may be eliminated from autografts through positive selection, autologous transplantation may prove highly effective, especially when coupled with post-transplant immunotherapy. Some of these same methodologies have helped facilitate the use of autologous grafts for transplantation in patients with chronic myelogenous leukemia without allogeneic donors. Advances in the supportive care of transplant patients, including the pretransplant identification of those at risk from pulmonary complications and the use of cytokines to speed engraftment, have reduced morbidity and mortality to such a degree that it is appropriate to consider high-dose therapy and stem cell reconstitution in patients with nonmalignant diseases. The impressive advances that have occurred in transplantation for thalassemia are described by pioneers in their area of investigation. The burgeoning field of transplantation for autoimmune disorders, including its immunobiologic basis and soon-to- be-realized clinical potential, is also summarized. Continued progress in the use of high-dose therapy with stem cell rescue for the treatment of pediatric tumors, which derives in part from improved supportive care, is detailed. The sobering voice of the health care economists underscores the necessary limitations to our seemingly unbridled imagination. Cost- consciousness and financial know-how will need to be reflected in future study designs. Given the seemingly endless applications of our technology, strategies to insure its cost-effectiveness will be necessary. Continued financial support for laboratory investigation and for the clinical experiments. …

Titre
Blood Stem Cell Transplantation
Auteur
Jane N. Winter
Éditeur
Springer
Année de publication
2012
État de l'article
Neu
Reliure
Taschenbuch
Langue
anglais
ISBN à 10 chiffres
1461379164
ISBN à 13 chiffres
9781461379164
Poids de l'article
657 grammes
Dimensions
235x155x24 mm
Série
Livre 92 sur 180: Cancer Treatment and Research

AHA-BUCH GmbH

Einbeck, Allemagne

Vendeur avec une évaluation de 5 étoiles

Vendeur AbeBooks depuis 14 août 2006

Frais d'expédition de Allemagne vers Etats-Unis

Article7 à 10 jours ouvrés5 à 7 jours ouvrés
Premier articleEUR 35,00EUR 45,00
Les délais de livraison sont fixés par les vendeurs et varient en fonction du transporteur et du lieu. Les commandes transitant par les douanes peuvent être retardées et les acheteurs sont responsables de tous les droits ou frais associés. Les vendeurs peuvent vous contacter au sujet de frais supplémentaires afin de couvrir toute augmentation des coûts d'expédition de vos articles.

Modes de paiement

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay
  • Chèque
  • Paypal
  • Virement bancaire

Description de la boutique

Das Unternehmen AHA-BUCH GmbH: Seit der Gründung von AHA-BUCH im Juli 2005 ist unser Hauptziel, zufriedenen Kunden so schnell und so preisgünstig wie möglich ihren Bücherwunsch zu erfüllen. Unsere Firma beschäftigt 16 Mitarbeiter, die nur ein Ziel kennen: den Kunden und seine Wünsche! Auf über 3700 m2 Fläche haben wir über 100.000 Bücher, Modernes Antiquariat und Spiele auf Lager.

Spécialité

Kinderbücher & Kinderhör Casetten, German Books, Software, Natur & Tiere, Ratgeber, Sachbücher, Englische Bücher, Medizin & Gesundheit, Universität & Studium

Profil professionnel du vendeur

AHA-BUCH GmbH

Garlebsen 48
Einbeck, Allemagne 37574

Empreinte

Informations sur le vendeur:

AHA-BUCH GmbH
représenté par le directeur général Christel Glass
Garlebsen 48
37574 Einbeck
Alemagne
Téléphone: 055639996039
Fax: 055639995974
E-Mail: abebooks@aha-buch.de
USt-IdNr.: DE261904229
inscrit à Registre du commerce Amtsgerichtes Göttingen
Handelsregisternummer HRB 200691

Modes alternatifs de règlement des différends :
La Commission européenne fournit une plate-forme de règlement extrajudiciaire des litiges en ligne (plate-forme ODR), accessible sous https://ec.europa.eu/odr.

Nous sommes membres de l’initiative « FairCommerce » depuis le 25.05.2018.
Pour plus d’informations, voir www.fair-commerce.de.